Literature DB >> 20846153

Hypermethylation of carcinogen metabolism genes, CYP1A1, CYP2A13 and GSTM1 genes in head and neck cancer.

R Sharma1, N K Panda, M Khullar.   

Abstract

OBJECTIVES: To investigate the role of aberrant hypermethylation of carcinogen metabolism pathway genes, CYP1A1, CYP2A13 and GSTM1 in head and neck cancer independently as well as its relation to tobacco and alcohol consumption and CYP1A1 and CYP2A13 polymorphisms in Indian population.
METHODS: Seventy-three histologically confirmed head and neck cancer patients undergoing treatment in Postgraduate Institute of Medical Education and Research, Chandigarh, India were recruited. Non-cancerous tissues were obtained from 19 trauma subjects undergoing maxillofacial surgery. Methylation-specific PCR was performed to determine the methylation status of selected genes.
RESULTS: The aberrant hypermethylation of CYP1A1, CYP2A13 and GSTM1 genes was found in cancer tissues with frequency of about 39.7%, 27.4%, and 58.1%, respectively, and in normal healthy tissues with a frequency of about 10.5%, 15.8%, and 20.0%, respectively. Hypermethylation of CYP1A1 (P 0.027) and GSTM1 (P 0.010) showed significant association with head and neck cancer. We also observed significant interaction between smoking and methylation status of CYP1A1 (P 0.029) and CYP2A13 (P -0.034) in head and neck cancer. No association was observed between methylation status and alcohol consumption, clinical features and genetic polymorphisms of CYP1A1 and CYP2A13.
CONCLUSIONS: Hypermethylation of carcinogen metabolism pathway genes independently and in interaction with smoking is associated with increased risk of head and neck cancer.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20846153     DOI: 10.1111/j.1601-0825.2010.01676.x

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  13 in total

1.  CYP1A1 MspI polymorphism and the risk of oral squamous cell carcinoma: Evidence from a meta-analysis.

Authors:  Shang Xie; Chongdai Luo; Xiaofeng Shan; Shushan Zhao; Jing He; Zhigang Cai
Journal:  Mol Clin Oncol       Date:  2016-02-05

2.  DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract.

Authors:  Samson Mani; Katarzyna Szymańska; Cyrille Cuenin; David Zaridze; Karen Balassiano; Sheila C S Lima; Elena Matos; Alexander Daudt; Sergio Koifman; Victor Wunsch Filho; Ana M B Menezes; Maria Paula Curado; Gilles Ferro; Thomas Vaissière; Bakary S Sylla; Massimo Tommasino; Luis Felipe Ribeiro Pinto; Paolo Boffetta; Pierre Hainaut; Paul Brennan; Zdenko Herceg
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

3.  Quantitative assessment of the association between GSTM1 null genotype and laryngeal cancer risk.

Authors:  Hui Xiao; Minghua Li; Linli Tian; Bin Zha; Ming Liu; Hongchao Yao
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-09-13       Impact factor: 2.503

4.  Human endometrial DNA methylome is cycle-dependent and is associated with gene expression regulation.

Authors:  Sahar Houshdaran; Zara Zelenko; Juan C Irwin; Linda C Giudice
Journal:  Mol Endocrinol       Date:  2014-05-30

5.  Portrait of DNA methylated genes predictive of poor prognosis in head and neck cancer and the implication for targeted therapy.

Authors:  Jessica Hier; Olivia Vachon; Allison Bernstein; Iman Ibrahim; Alex Mlynarek; Michael Hier; Moulay A Alaoui-Jamali; Mariana Maschietto; Sabrina Daniela da Silva
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

6.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

7.  MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.

Authors:  Kavita M Pattani; Ethan Soudry; Chad A Glazer; Michael F Ochs; Hao Wang; Juliana Schussel; Wenyue Sun; Patrick Hennessey; Wojciech Mydlarz; Myriam Loyo; Semra Demokan; Ian M Smith; Joseph A Califano
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

Review 8.  Polymorphisms in the human cytochrome P450 and arylamine N-acetyltransferase: susceptibility to head and neck cancers.

Authors:  Rim Khlifi; Olfa Messaoud; Ahmed Rebai; Amel Hamza-Chaffai
Journal:  Biomed Res Int       Date:  2013-09-16       Impact factor: 3.411

Review 9.  Epigenetic regulation of drug metabolism and transport.

Authors:  Lai Peng; Xiaobo Zhong
Journal:  Acta Pharm Sin B       Date:  2015-03-07       Impact factor: 11.413

10.  Outlier Analysis Defines Zinc Finger Gene Family DNA Methylation in Tumors and Saliva of Head and Neck Cancer Patients.

Authors:  Daria A Gaykalova; Rajita Vatapalli; Yingying Wei; Hua-Ling Tsai; Hao Wang; Chi Zhang; Patrick T Hennessey; Theresa Guo; Marietta Tan; Ryan Li; Julie Ahn; Zubair Khan; William H Westra; Justin A Bishop; David Zaboli; Wayne M Koch; Tanbir Khan; Michael F Ochs; Joseph A Califano
Journal:  PLoS One       Date:  2015-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.